as on November 19, 2025 at 9:38 pm IST
Day's Low
Day's High
0.97%
Downside
1.23%
Upside
52 Week's Low
52 Week's High
70.19%
Downside
0.51%
Upside
Check Insmed Incorporated market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$43.0B
EPS (TTM)
-6.1305
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-16.34
Industry PE ratio
19.200384615384614
PEG Ratio
0EBITDA
-978.8M
Revenue (TTM)
447.0M
Profit Margin
-264.83%
Return On Equity TTM
-165.69%
Track how Insmed Incorporated P/E has moved over time to understand its valuation trends.
Insmed Incorporated in the last 5 years
Lowest (-21.27x)
September 30, 2025
Today (-16.34x)
November 19, 2025
Industry (19.20x)
November 19, 2025
Highest (-3.61x)
June 30, 2023
Today’s Price to Earnings Ratio: -16.34x
Compare market cap, revenue, PE, and other key metrics of Insmed Incorporated with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $43.0B | 407.48% | -16.34 | -264.83% | |
| BUY | $60.8B | 273.39% | 1439.19 | 1.36% | |
| BUY | $111.3B | 105.46% | 30.59 | 31.35% | |
| BUY | $74.6B | 40.92% | 16.89 | 32.13% |
The Insmed Incorporated stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Insmed Incorporated investment value today
Current value as on today
₹2,79,913
Returns
₹1,79,913
(+179.91%)
Returns from Insmed Incorporated Stock
₹1,74,837 (+174.84%)
Dollar Returns*
₹5,076 (+5.08%)
Based on 23 analysts
95.65%
Buy
4.35%
Hold
0.00%
Sell
Based on 23 analysts, 95.65% of analysts recommend a 'BUY' rating for Insmed Incorporated. Average target price of $213.65
Get share price movements and forecasts by analysts on Insmed Incorporated.
What analysts predicted
5.17%UPSIDE
Target Price
$213.65
Current Price
$202.61
Analyzed by
23 Analysts
Target
$213.65
Insmed Incorporated target price $213.65, a slight upside of 5.17% compared to current price of $202.61. According to 23 analysts rating.
Investment in Insmed Incorporated Shares on INDmoney has grown by 181.63% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:181.63% versus previous 30 day period
Search interest for Insmed Incorporated Stock has increased by 724% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:724% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Insmed Incorporated has seen consistent revenue growth over the last three quarters, with revenue increasing from $92.82 million to $142.34 million. This represents an average increase of 19.1% per quarter.
Best in 1 Year
![]()
In the last 1 year, INSM has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
![]()
In the last 3 years, INSM stock has moved up by 933.9%
Best in 3 Years
![]()
In the last 3 years, INSM has outperformed top 5 stocks with highest market-cap in its industry
Profit Down
![]()
Insmed Incorporated has experienced declining net profits over the last five quarters. Specifically, their net profit decreased from -220.52 million dollars to -370.02 million dollars, which represents an average reduction of 14.0% each quarter.
| Organisation | Insmed Incorporated |
| Headquarters | 700 US Highway 202/206, Bridgewater, NJ, United States, 08807 |
| Industry | Health Technology |
| CEO | Mr. William H. Lewis J.D., M.B.A. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Martina Flammer M.B.A., M.D. | Chief Medical Officer |
Bryan Dunn | Vice President of Investor Relations |
Mr. Michael Alexander Smith J.D. | Chief Legal Officer & Corporate Secretary |
Ms. Claire Mulhearn | Vice President of Corporate Communications |
Ms. S. Nicole Schaeffer M.B.A. | Chief People Strategy Officer |
Ms. Sara M. Bonstein M.B.A. | Chief Financial Officer |
Mr. John Drayton Wise M.B.A. | Consultant |
Mr. Brian K. Kaspar Ph.D. | Chief Scientific Officer |
Mr. William H. Lewis J.D., M.B.A. | President, CEO & Chairman |
Mr. Roger Adsett M.B.A. | Chief Operating Officer |
Insmed Incorporated share price today is $202.61 as on . Insmed Incorporated share today touched a day high of $205.11 and a low of $200.65.
Insmed Incorporated share touched a 52 week high of $203.65 on and a 52 week low of $60.4 on . Insmed Incorporated stock price today i.e. is trending at $202.61,which is 0.51% down from its 52 week high and 235.45% up from its 52 week low.
Insmed Incorporated market capitalisation is $0.04T as on .
Indian investors can start investing in Insmed Incorporated (INSM) shares with as little as ₹88.6 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.00 in Insmed Incorporated stock (as per the Rupee-Dollar exchange rate as on ).
Based on Insmed Incorporated share’s latest price of $202.61 as on November 19, 2025 at 9:38 pm IST, you will get 0.0494 shares of Insmed Incorporated. Learn more about
fractional shares .
Insmed Incorporated stock has given 407.48% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?